Leen Kawas, Athira CEO

An­oth­er biotech — Seat­tle-based Athi­ra — files for an IPO, hop­ing to fi­nal­ly break through in Alzheimer's

Yet an­oth­er biotech is aim­ing to go pub­lic, as this year’s IPO boom con­tin­ues to show no sign of abat­ing any time soon.

The newest …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.